Search research articles
Contact Us
Filters
Showing results (51-60 of 76) with videos related to
Page
of 8
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
December 30, 2020
DNA polymerase ι compensates for Fanconi anemia pathway deficiency by countering DNA replication stress
Rui Wang, Walter F Lenoir, Chao Wang, et al.
Molecular Cell
|
August 4, 2023
FACS-based genome-wide CRISPR screens define key regulators of DNA damage signaling pathways
Min Huang, Fuwen Yao, Litong Nie, et al.
Biorxiv : the Preprint Server for Biology
|
September 30, 2024
Therapeutic modulation of ROCK overcomes metabolic adaptation of cancer cells to OXPHOS inhibition and drives synergistic anti-tumor activity
Nicholas Blazanin, Xiaobing Liang, Iqbal Mahmud, et al.
Biorxiv : the Preprint Server for Biology
|
December 25, 2025
Functional modules predict cancer-relevant genetic interactions in mammalian cells
Chenchu Lin, Veronica Gheorghe, Juihsuan Chou, et al.
Genome Research
|
July 16, 2011
Application of microdroplet PCR for large-scale targeted bisulfite sequencing
H Kiyomi Komori, Sarah A LaMere, Ali Torkamani, et al.
Nature Communications
|
November 12, 2021
Discovery of putative tumor suppressors from CRISPR screens reveals rewired lipid metabolism in acute myeloid leukemia cells
W Frank Lenoir, Micaela Morgado, Peter C DeWeirdt, et al.
Nature Medicine
|
November 22, 2016
Genome-wide CRISPR screens reveal a Wnt-FZD5 signaling circuit as a druggable vulnerability of RNF43-mutant pancreatic tumors
Zachary Steinhart, Zvezdan Pavlovic, Megha Chandrashekhar, et al.
Nature Medicine
|
November 9, 2017
Corrigendum: Genome-wide CRISPR screens reveal a Wnt-FZD5 signaling circuit as a druggable vulnerability of RNF43-mutant pancreatic tumors
Zachary Steinhart, Zvezdan Pavlovic, Megha Chandrashekhar, et al.
JCI Insight
|
December 7, 2023
CRISPR screening identifies BET and mTOR inhibitor synergy in cholangiocarcinoma through serine glycine one carbon
Yan Zhu, Dengyong Zhang, Pooja Shukla, et al.
Scientific Reports
|
January 31, 2019
A rapid in vitro methodology for simultaneous target discovery and antibody generation against functional cell subpopulations
Allison M L Nixon, Alejandro Duque, Nicholas Yelle, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 76) with videos related to
Sort By:
Page
of 8
Proceedings of the National Academy of Sciences of the United States of America
|
December 30, 2020
DNA polymerase ι compensates for Fanconi anemia pathway deficiency by countering DNA replication stress
Rui Wang, Walter F Lenoir, Chao Wang, et al.
Molecular Cell
|
August 4, 2023
FACS-based genome-wide CRISPR screens define key regulators of DNA damage signaling pathways
Min Huang, Fuwen Yao, Litong Nie, et al.
Biorxiv : the Preprint Server for Biology
|
September 30, 2024
Therapeutic modulation of ROCK overcomes metabolic adaptation of cancer cells to OXPHOS inhibition and drives synergistic anti-tumor activity
Nicholas Blazanin, Xiaobing Liang, Iqbal Mahmud, et al.
Biorxiv : the Preprint Server for Biology
|
December 25, 2025
Functional modules predict cancer-relevant genetic interactions in mammalian cells
Chenchu Lin, Veronica Gheorghe, Juihsuan Chou, et al.
Genome Research
|
July 16, 2011
Application of microdroplet PCR for large-scale targeted bisulfite sequencing
H Kiyomi Komori, Sarah A LaMere, Ali Torkamani, et al.
Nature Communications
|
November 12, 2021
Discovery of putative tumor suppressors from CRISPR screens reveals rewired lipid metabolism in acute myeloid leukemia cells
W Frank Lenoir, Micaela Morgado, Peter C DeWeirdt, et al.
Nature Medicine
|
November 22, 2016
Genome-wide CRISPR screens reveal a Wnt-FZD5 signaling circuit as a druggable vulnerability of RNF43-mutant pancreatic tumors
Zachary Steinhart, Zvezdan Pavlovic, Megha Chandrashekhar, et al.
Nature Medicine
|
November 9, 2017
Corrigendum: Genome-wide CRISPR screens reveal a Wnt-FZD5 signaling circuit as a druggable vulnerability of RNF43-mutant pancreatic tumors
Zachary Steinhart, Zvezdan Pavlovic, Megha Chandrashekhar, et al.
JCI Insight
|
December 7, 2023
CRISPR screening identifies BET and mTOR inhibitor synergy in cholangiocarcinoma through serine glycine one carbon
Yan Zhu, Dengyong Zhang, Pooja Shukla, et al.
Scientific Reports
|
January 31, 2019
A rapid in vitro methodology for simultaneous target discovery and antibody generation against functional cell subpopulations
Allison M L Nixon, Alejandro Duque, Nicholas Yelle, et al.
Page
of 8